In Kidney Allografts Inflammation in Scarred Areas is not a Reflection of Chronic Active T Cell-Mediated Rejection

被引：1
|
作者：
Halloran, Philip [1 ,2 ]
Chang, Jessica [1 ]
Famulski, Konrad S. [1 ,3 ]
机构：
[1] Alberta Transplant Appl Genom Ctr, Edmonton, AB, Canada
[2] Univ Alberta, Med, Edmonton, AB, Canada
[3] Univ Alberta, Lab Med & Pathol, Edmonton, AB, Canada
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
D O I：
10.1097/01.tp.0000542959.10675.b6
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
504.3
引用
收藏
页码：S268 / S269
页数：2
相关论文
共 50 条
  • [1] T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts
    Lefaucheur, Carmen
    Gosset, Clement
    Rabant, Marion
    Viglietti, Denis
    Verine, Jerome
    Aubert, Olivier
    Louis, Kevin
    Glotz, Denis
    Legendre, Christophe
    Van Huyen, Jean-Paul Duong
    Loupy, Alexandre
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (02) : 377 - 390
  • [2] Inflammation in Scarred Areas (I-IFTA) is a Reflection of Parenchymal Injury (Response to Wounding) Not T Cell-Mediated Rejection.
    Halloran, P.
    Chang, J.
    Famulski, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 328 - 328
  • [3] Inflammation in Scarred Areas (i-IF/TA): Defining the Response to Standard Treatment of T cell-mediated Rejection in Kidney Recipients
    Viglietti, Denis
    Aubert, Olivier
    Van Huyen, Jean-Paul Duong
    Loupy, Alexandre
    Lefaucheur, Carmen
    [J]. TRANSPLANTATION, 2018, 102 : S26 - S26
  • [4] Revisiting acute T cell-mediated rejection in kidney allografts
    Helantera, Ilkka
    Mengel, Michael
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (03) : 681 - 682
  • [5] Inflammation in Scarred Areas (i-IF/TA): Defining the Response to Standard Treatment of T Cell-Mediated Rejection in Kidney Recipients.
    Viglietti, D.
    Aubert, O.
    Van Huyen, J-P. Duong
    Loupy, A.
    Lefaucheur, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 423 - 424
  • [6] The Histological Spectrum and Clinical Significance of T Cell-mediated Rejection of Kidney Allografts
    Filippone, Edward J.
    Farber, John L.
    [J]. TRANSPLANTATION, 2023, 107 (05) : 1042 - 1055
  • [7] Urinary Cell mRNA Profile Diagnosis of Borderline T Cell-Mediated Rejection in Kidney Allografts
    Salinas, Thalia
    Li, Carol Y.
    Snopkowski, Catherine
    Chen, Kevin
    Albakry, Shady Y.
    Salvatore, Steven
    Seshan, Surya V.
    Lee, John R.
    Muthukumar, Thangamani
    Dadhania, Darshana M.
    Suthanthiran, Manikkam
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 625 - 626
  • [8] INFLAMMATION IN SCARED AREAS IN THE KIDNEY ALLOGRAFT: MAJOR IMPACT OF T CELL-MEDIATED REJECTION AND UNDER-IMMUNOSUPPRESSION
    Gosset, Clement
    Viglietti, Denis
    Rabant, Marion
    Loupy, Alexandre
    Lefaucheur, Carmen
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 63 - 63
  • [9] Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy
    Kung, Vanderlene L.
    Sandhu, Rana
    Haas, Mark
    Huang, Edmund
    [J]. KIDNEY INTERNATIONAL, 2021, 100 (02) : 391 - 400
  • [10] Do we need to treat chronic active T cell-mediated rejection?
    Mengel, Michael
    Lubetzky, Michelle
    [J]. KIDNEY INTERNATIONAL, 2021, 100 (02) : 275 - 277
12345